Total Payments
$3,649
2024 Payments
$1,227
Companies
16
Transactions
217
Medicare Patients
5,628
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$3,397 (93.1%)
Education$252.20 (6.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,397 | 213 | 93.1% |
| Education | $252.20 | 4 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $884.02 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $693.76 | 59 | $0 (2024) |
| ABBVIE INC. | $510.42 | 35 | $0 (2024) |
| PFIZER INC. | $265.87 | 14 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $237.84 | 3 | $0 (2018) |
| Biohaven Pharmaceutical Holding Company Ltd. | $174.03 | 8 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $164.82 | 7 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $154.76 | 9 | $0 (2021) |
| Eisai Inc. | $147.67 | 2 | $0 (2024) |
| Amgen Inc. | $118.82 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,227 | 68 | UCB, Inc. ($533.90) |
| 2023 | $746.34 | 48 | UCB, Inc. ($331.09) |
| 2022 | $663.02 | 49 | Novartis Pharmaceuticals Corporation ($187.25) |
| 2021 | $469.87 | 31 | AbbVie Inc. ($240.72) |
| 2020 | $102.54 | 7 | Allergan, Inc. ($73.50) |
| 2019 | $132.66 | 7 | Genentech USA, Inc. ($39.60) |
| 2018 | $196.06 | 6 | Teva Pharmaceuticals USA, Inc. ($126.60) |
| 2017 | $111.24 | 1 | Teva Pharmaceuticals USA, Inc. ($111.24) |
All Payment Transactions
217 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neurology | ||||||
| 12/11/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Neurology | ||||||
| 11/27/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $33.32 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Neurology | ||||||
| 11/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Neurology | ||||||
| 11/02/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Neurology | ||||||
| 11/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: Neurology | ||||||
| 11/01/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: Neurology | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Neurology | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: Neurology | ||||||
| 10/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Neurology | ||||||
| 09/13/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Neurology | ||||||
| 09/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: PAIN | ||||||
| 08/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Neurology | ||||||
| 08/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: PAIN | ||||||
| 07/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Neurology | ||||||
| 07/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,253 | 2,330 | $445,960 | $256,922 |
| 2022 | 12 | 1,330 | 2,297 | $443,055 | $253,249 |
| 2021 | 12 | 1,519 | 2,619 | $504,340 | $297,359 |
| 2020 | 13 | 1,526 | 2,878 | $537,210 | $298,482 |
Total Patients
5,628
Total Services
10,124
Medicare Billing
$1.1M
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 372 | 676 | $98,020 | $62,622 | 63.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 174 | 190 | $114,000 | $58,471 | 51.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 117 | 580 | $84,100 | $56,993 | 67.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 136 | 153 | $42,840 | $21,066 | 49.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 202 | $20,200 | $13,200 | 65.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 57 | 139 | $24,325 | $10,904 | 44.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 65 | 65 | $18,850 | $10,348 | 54.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 78 | $15,600 | $10,017 | 64.2% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 38 | 38 | $19,000 | $8,653 | 45.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 19 | 19 | $5,225 | $2,639 | 50.5% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 174 | 190 | $3,800 | $2,010 | 52.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 410 | 694 | $100,630 | $64,709 | 64.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 151 | 662 | $95,990 | $56,132 | 58.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 164 | 170 | $102,000 | $52,767 | 51.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 169 | 191 | $53,480 | $31,012 | 58.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 85 | 85 | $24,650 | $12,648 | 51.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 52 | 122 | $21,350 | $10,179 | 47.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 45 | $9,000 | $6,710 | 74.6% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 28 | 28 | $14,000 | $6,681 | 47.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 96 | $9,600 | $5,658 | 58.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 22 | 22 | $6,050 | $3,137 | 51.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,925 | $1,826 | 62.4% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2022 | 163 | 169 | $3,380 | $1,790 | 52.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 453 | 748 | $108,460 | $72,303 | 66.7% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 197 | 209 | $125,400 | $64,443 | 51.4% |
About Nancy Cao, MD, PHD
Nancy Cao, MD, PHD is a Neurology healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194703207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nancy Cao, MD, PHD has received a total of $3,649 in payments from pharmaceutical and medical device companies, with $1,227 received in 2024. These payments were reported across 217 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,397).
As a Medicare-enrolled provider, Cao has provided services to 5,628 Medicare beneficiaries, totaling 10,124 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Southfield, MI
- Active Since 01/09/2006
- Last Updated 04/22/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1194703207
Products in Payments
- KESIMPTA (Drug) $671.94
- UBRELVY (Drug) $554.77
- NURTEC ODT (Drug) $523.45
- Briviact (Drug) $428.37
- Nayzilam (Drug) $416.56
- XYWAV (Drug) $164.82
- Leqembi (Drug) $147.67
- Aimovig (Biological) $118.82
- OCREVUS (Biological) $70.90
- TYSABRI (Biological) $63.50
- COMIRNATY (Biological) $56.37
- Rystiggo (Drug) $39.09
- ZEPOSIA (Drug) $29.76
- QULIPTA (Drug) $29.15
- ADUHELM (Biological) $23.40
- AIMOVIG (Biological) $21.82
- Sunosi (Drug) $21.15
- AJOVY (Drug) $15.40
- PAXLOVID (Drug) $14.84
- EMGALITY (Drug) $14.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Southfield
Dr. Anthony Emmer, D.o, D.O
Neurology — Payments: $214,206
Neurology $214,206
Dr. Lawrence Eilender, Md, MD
Neurology — Payments: $84,940
Neurology $84,940
Dr. Tessy Jenkins, M.d, M.D
Neurology — Payments: $34,604
Neurology $34,604
Dr. William Leuchter, M.d, M.D
Neurology — Payments: $7,439
Neurology $7,439
Dr. Rashmi Gupta, Md, MD
Neurology — Payments: $7,116
Neurology $7,116
Ahmad Ahmad, Md, MD
Neurology — Payments: $3,993
Neurology $3,993